Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $12.00 million. The enterprise value is $19.90 million.

Market Cap	12.00M
Enterprise Value	19.90M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CLDI has 11.11 million shares outstanding. The number of shares has increased by 1,173.82% in one year.

Shares Outstanding	11.11M
Shares Change (YoY)	+1,173.82%
Shares Change (QoQ)	+49.86%
Owned by Insiders (%)	9.48%
Owned by Institutions (%)	2.94%
Float	9.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio	0.12
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-222.49%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$607,707
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLDI has paid $20,000 in taxes.

Income Tax	20,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.40% in the last 52 weeks. The beta is 0.60, so CLDI's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-95.40%
50-Day Moving Average	1.14
200-Day Moving Average	3.38
Relative Strength Index (RSI)	48.79
Average Volume (20 Days)	691,883

Short Selling Information

The latest short interest is 110,832, so 1.00% of the outstanding shares have been sold short.

Short Interest	110,832
Short Previous Month	282,137
Short % of Shares Out	1.00%
Short % of Float	1.21%
Short Ratio (days to cover)	1.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.57M
Pretax Income	-29.96M
Net Income	-24.92M
EBITDA	-29.18M
EBIT	-29.57M
Earnings Per Share (EPS)	-$7.17

Balance Sheet

The company has $836,000 in cash and $8.73 million in debt, giving a net cash position of -$7.90 million or -$0.71 per share.

Cash & Cash Equivalents	836,000
Total Debt	8.73M
Net Cash	-7.90M
Net Cash Per Share	-$0.71
Equity (Book Value)	-11.75M
Book Value Per Share	-1.82
Working Capital	-11.43M

Cash Flow

In the last 12 months, operating cash flow was -$28.03 million and capital expenditures -$147,000, giving a free cash flow of -$28.18 million.

Operating Cash Flow	-28.03M
Capital Expenditures	-147,000
Free Cash Flow	-28.18M
FCF Per Share	-$2.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,173.82%
Shareholder Yield	-1,173.82%
Earnings Yield	-207.64%
FCF Yield	-234.80%

Analyst Forecast

The average price target for CLDI is $16.67, which is 1,443.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.67
Price Target Difference	1,443.52%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 15, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 15, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1